// App-Quantinova.ai

M4178 2016 AHA : PBI-4050 Therapy Selectively Improves Pulmonary Hypertension, Lung Remodeling and Right Ventricular Function in Heart Failure With Reduced Ejection Fraction

Researchers

Presenter

  • Martin Sirois

Principal Investigators

  • Angelo Calderone

  • Jean-Claude Tardif

  • Yanfen Shi

  • Lyne Gagnon

  • Jocelyn Dupuis

Medical Centers

  • Institut de Rhumatologie, Montreal, QC, Canada

  • al, QC, Canada

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with reduced ejection fraction

  • Pulmonary arterial hypertension

  • Myocardial infarction

  • Right ventricular dysfunction

  • Congestive heart failure

  • Hypertension

Biomarkers

  • Wall motion score index

Drug/Treatment

  • PBI4050

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved